Classic Kaposi sarcoma: Experience at Rabin Medical Center in Israel

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 21, Issue 5, 1998, Pages 498-500

  Fenig, Eyal ^a,b   Brenner, Baruch ^a   Rakowsky, Erica ^a   Lapidoth, Moshe ^a   Katz, Alan ^a   Sulkes, Aaron ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

Chemotherapy; Epidemiology; Kaposi sarcoma; Radiotherapy

Indexed keywords

ETOPOSIDE; VINBLASTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; ISRAEL; JEW; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; RACE DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; ARABS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; ISRAEL; JEWS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SARCOMA, KAPOSI; SURVIVAL ANALYSIS;

EID: 0031751629     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199810000-00016     Document Type: Article

References (17)

1. Cox FH, Helwig EB, Kaposi's sarcoma. Cancer 1959;12:289-98.
2. Friedman-Kien A, Saltzman BR. Clinical manifestations of classical endemic African and epidemic AIDS-associated Kaposi's sarcoma. J Am Acad Dermatol 1990;22:1237-50.
3. Tappero JW, Contant MA, Wolfe SF, et al. Kaposi's sarcoma, epidemiology, pathogenesis, histology, clinical criteria and therapy. J Am Acad Dermatol 1993;28:371-95.
4. Wahman A, Melnick SL, Rhame FS, et al. The epidemiology of classic, African and immunosuppressed Kaposi's sarcoma. Epidemiol Rev 1991;13:178-99.
5. Schwartz RA, Kaposi's sarcoma. In: Schwartz RA, ed. Skin cancer. recognition find management. New York: Springer, 1988;80-98.
6. Friedman-Birnbaum R, Weltfriend S, Katz I. Kaposi's sarcoma: retrospective study of 67 cases with the classical form. Dermatologica 1990;180:13-7.
7. Tzfoni EE, Scherman L, Battat S, et al. No HLA antigen is significant in classic Kaposi's sarcoma. J Am Acad Dermatol 1993;28:118-9.
8. Kaloterakis A, Papasteriades C, Filioton A, et al. HLA in familial and nonfamilial Mediterranean Kaposi's sarcoma in Greece. Tissue Antigen 1995;45:117-9.
9. Stein ME, Spencer D, Dansey R, et al. Lymphoproliferative disorder in non-AIDS associated Kaposi's sarcoma, the Johannesburg Hospital experience, 1980-1992. S Afr Med J 1994;84:484-8.
10. Zurrida S, Bartoli C, Nole F, et al. Classic Kaposi's sarcoma: a review of 90 cases. J Dermatol 1992;19:548-52.
11. Mitsuyasu RT, Groojman JE. Biology and therapy of Kaposi's sarcoma. Semin Oncol 1984;11:53-8.
12. Holecek MJ, Harwood AR. Radiotherapy of Kaposi's sarcoma. Cancer 1978;91:1733-8.
13. Cooper JS. The influence of dose on long-term control of classic Kaposi's sarcoma by radiotherapy. Int J Radiat Oncol Biol Phys 1988;15:1141-6.
14. Brambilla L, Labianca R, Boneschi V, et al. Mediterranean Kaposi's sarcoma in the elderly. a randomized study of oral etoposide versus vinblastine. Cancer 1994;74:2873-8.
15. Tucker SB, Winkelmann RK. Treatment of Kaposi's sarcoma with vinblastine. Arch Dermatol 1976;112:958-61.
16. Lospalluti M, Mastrolodaro M, Laconsole F, Conte A, Rantuccio F. Classical Kaposi's sarcoma: a survey of 167 cases observed in Bari, South Italy. Dermatology 1995;191:104-8.
17. Azzarelli A, Mazzaferro V, Quagliuolo V, et al. Kaposi's sarcoma: malignant tumor or proliferative disorder. Eur J Clin Oncol 1988;24:973-8.